US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 1.1200
  • -0.0300-2.61%
Close Dec 13 16:00 ET
  • 1.1197
  • -0.0003-0.03%
Post 20:01 ET
140.90MMarket Cap-5.33P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Atossa Therapeutics Earnings Reports

  • Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 12 12:18 ET

  • Atossa Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 12:18 ET

  • Atossa Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 09:10 ET

  • Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 12 09:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 10, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data